Nuwellis (NUWE) vs Valion Bio (VBIO)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
Nuwellis is the larger company by market cap ($1.8 million vs $1.0 million), about 1.8 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | NUWE | VBIO |
|---|---|---|
| Share price | $3.41 | $0.4806 |
| Market cap | $1.84M | $1.04M |
| 1-day change | -10.50% | -10.98% |
| P/E ratio (TTM) | 0.00 | — |
| EPS (TTM) | $3,609.63 | $-177.91 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $8.27M | — |
| Revenue growth (YoY) | -5.38% | — |
| Net income (latest FY) | $-17.52M | $-8.88M |
| Gross margin | 61.96% | — |
| Operating margin | -134.29% | — |
| Net margin | -211.86% | — |
| 52-week high | $1,556.10 | $67.50 |
| 52-week low | $2.52 | $0.472 |
| Distance from 52-week high | -99.78% | -99.29% |
| Average volume | 829.19K | 1.78M |
| Shares outstanding | 540.91K | 2.16M |
| Employees | 38 | 52 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Nuwellis
NUWE stock →Nuwellis, Inc., a medical device company, develops, manufactures, and commercializes medical devices used in ultrafiltration therapy. The company provides Aquadex FlexFlow and Aquadex SmartFlow systems, which are used to treat patients suffering from fluid overload due to heart failure, as well as Aquadex SmartFlow system for temporary use in adult and pediatric patients.
Health Care · Biotechnology: Electromedical & Electrotherapeutic Apparatus · 38 employees
About Valion Bio
VBIO stock →Valion Bio, Inc. operates as a late-stage biopharmaceutical company.
Health Care · Biotechnology: Electromedical & Electrotherapeutic Apparatus · 52 employees
NUWE vs VBIO FAQ
Which is bigger, Nuwellis or Valion Bio?
Nuwellis (NUWE) is larger, with a market capitalization of $1.84M compared with $1.04M for Valion Bio (VBIO).
Are Nuwellis and Valion Bio in the same industry?
Yes. Both are classified in the Biotechnology: Electromedical & Electrotherapeutic Apparatus industry within the Health Care sector.